Drug Patent Expirations in September 2009

Drug Patent Expirations in September 2009

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in September 2009


*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
FARESTON Gtx Inc toremifene citrate 4,696,949 Sep 29, 2009
FELBATOL Meda Pharms felbamate 4,978,680 Sep 26, 2009
FELBATOL Meda Pharms felbamate 5,082,861 Sep 26, 2009
GLUCOTROL XL Pfizer glipizide 5,024,843 Sep 5, 2009
GLUCOTROL XL Pfizer glipizide 5,091,190 Sep 5, 2009
IMPLANON Organon Usa Inc etonogestrel 5,150,718 Sep 29, 2009
NEORAL Novartis cyclosporine 5,866,159 Sep 13, 2009
NEORAL Novartis cyclosporine 5,916,589 Sep 13, 2009
NEORAL Novartis cyclosporine 5,962,014 Sep 13, 2009
NEORAL Novartis cyclosporine 5,962,017 Sep 13, 2009
NEORAL Novartis cyclosporine 6,007,840 Sep 13, 2009
NEORAL Novartis cyclosporine 6,024,978 Sep 13, 2009
PRIMAXIN Merck cilastatin sodium; imipenem 5,147,868 Sep 15, 2009
STARLIX Novartis nateglinide RE34878 Sep 8, 2009
TOBRADEX Alcon dexamethasone; tobramycin 5,149,694 Sep 22, 2009
TOBRADEX ST Alcon dexamethasone; tobramycin 5,149,694 Sep 22, 2009
TOBRASONE Alcon fluorometholone acetate; tobramycin 5,149,693 Sep 22, 2009
XALATAN Pharmacia And Upjohn latanoprost 6,429,226 Sep 6, 2009

Courtesy of DrugPatentWatch.com

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.